Chemoinformaics analysis of 4-(4-O-Methyl-Alpha-D-Glucuronoside)-L-Arabinose
| Molecular Weight | 400.383 | nRot | 3 |
| Heavy Atom Molecular Weight | 380.223 | nRig | 26 |
| Exact Molecular Weight | 400.116 | nRing | 5 |
| Solubility: LogS | -3.798 | nHRing | 2 |
| Solubility: LogP | 1.284 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 54.8219 |
| nHD | 2 | BPOL | 29.6121 |
| QED | 0.755 |
| Synth | 3.814 |
| Natural Product Likeliness | 1.66 |
| NR-PPAR-gamma | 0.135 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.103 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.867 |
| MDCK | 0.0000189 |
| BBB | 0.05 |
| PPB | 0.961812 |
| VDSS | 1.088 |
| FU | 0.0372115 |
| CYP1A2-inh | 0.079 |
| CYP1A2-sub | 0.962 |
| CYP2c19-inh | 0.473 |
| CYP2c19-sub | 0.873 |
| CYP2c9-inh | 0.468 |
| CYP2c9-sub | 0.857 |
| CYP2d6-inh | 0.284 |
| CYP2d6-sub | 0.297 |
| CYP3a4-inh | 0.907 |
| CYP3a4-sub | 0.902 |
| CL | 7.512 |
| T12 | 0.41 |
| hERG | 0.058 |
| Ames | 0.024 |
| ROA | 0.125 |
| SkinSen | 0.147 |
| Carcinogencity | 0.132 |
| EI | 0.061 |
| Respiratory | 0.786 |
| NR-Aromatase | 0.63 |
| Antiviral | Yes |
| Prediction | 0.936533 |